自1952年 Ducci 报道肾上腺糖皮质激素(以下简称皮质激素)对重型肝炎治疗有效以来,临床上一度较广泛地将其用于肝病治疗。以后,在与病毒相关的慢性活动性肝炎(CAH)治疗中各家学者持有不同的观点,因而皮质激素的应用受到限制。随着经验的积累,皮质激素在肝病应用的适应征渐趋明朗,本文仅就皮质激素在肝病临床应用的现况作一扼要介绍。 Since 1952 Ducci reported that glucocorticoids (hereinafter referred to as corticosteroids) for the treatment of severe hepatitis effective since the clinic once more widely used for liver disease treatment. Since then, various scholars hold different opinions in the treatment of virus-related chronic active hepatitis (CAH), and the application of corticosteroids is limited. With the accumulation of experience, the application of corticosteroids in liver disease becomes increasingly clear indications, this article only on clinical application of corticosteroids in liver disease make a brief introduction.